BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kissling E, Hooiveld M, Brytting M, Vilcu AM, de Lange M, Martínez-Baz I, Sigerson D, Enkirch T, Belhillil S, Meijer A, Castilla J, William N, Carnahan A, Falchi A, Hendriksen J, Casado I, Murray J, Enouf V, Dijkstra F, Marques DFP, Valenciano M. Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020. Influenza Other Respir Viruses 2021;15:429-38. [PMID: 33481344 DOI: 10.1111/irv.12839] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang B, Huang Q, Jia M, Xue X, Wang Q, Yang W, Feng L. Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis. Chinese Medical Journal 2022;Publish Ahead of Print. [DOI: 10.1097/cm9.0000000000002427] [Reference Citation Analysis]
2 van Laak A, Verhees R, Knottnerus JA, Hooiveld M, Winkens B, Dinant GJ. Impact of influenza vaccination on GP-diagnosed COVID-19 and all-cause mortality: a Dutch cohort study. BMJ Open 2022;12:e061727. [PMID: 36137620 DOI: 10.1136/bmjopen-2022-061727] [Reference Citation Analysis]
3 Satir A, Ersoy A, Demirci H, Ozturk M. Influenza and pneumococcal vaccination and COVID-19 in kidney transplant patients. Transpl Immunol 2022;75:101693. [PMID: 35963562 DOI: 10.1016/j.trim.2022.101693] [Reference Citation Analysis]
4 Kapoula GG, Vennou KE, Bagos PG. Influenza and pneumococcal vaccination and the risk of COVID-19: A systematic review and meta-analysis.. [DOI: 10.1101/2022.06.30.22277089] [Reference Citation Analysis]
5 Tayar E, Abdeen S, Alah MA, Chemaitelly H, Bougmiza I, Ayoub HH, Kaleeckal AH, Latif AN, Shaik RM, Al-romaihi HE, Al-thani MH, Bertollini R, Abu-raddad LJ, Al-khal A. Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar.. [DOI: 10.1101/2022.05.09.22274802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Pietraszek A, Sobieszczańska M, Makuch S, Dróżdż M, Mazur G, Agrawal S. Identification of Barriers Limiting the Use of Preventive Vaccinations against Influenza among the Elderly Population: A Cross-Sectional Analysis. Vaccines 2022;10:651. [DOI: 10.3390/vaccines10050651] [Reference Citation Analysis]
7 Stańczak-Mrozek KI, Sobczak A, Lipiński L, Sienkiewicz E, Makarewicz D, Topór-Mądry R, Pinkas J, Sierpiński RA. The Potential Benefits of the Influenza Vaccination on COVID-19 Mortality Rate-A Retrospective Analysis of Patients in Poland. Vaccines (Basel) 2021;10:5. [PMID: 35062666 DOI: 10.3390/vaccines10010005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lazova S, Velikova T. DYNAMICS OF CHILDHOOD RESPIRATORY INFECTIONS DURING THE COVID-19 PANDEMIC: THE EFFECT OF QUARANTINE АND BEYOND. CAJMHE 2021;2:153-61. [DOI: 10.47316/cajmhe.2021.2.3.04] [Reference Citation Analysis]
9 Bruxvoort KJ, Ackerson B, Sy LS, Bhavsar A, Tseng HF, Florea A, Luo Y, Tian Y, Solano Z, Widenmaier R, Shi M, Van Der Most R, Schmidt JE, Danier J, Breuer T, Qian L. Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults.. [DOI: 10.1101/2021.10.01.21264400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Huang K, Lin SW, Sheng WH, Wang CC. Influenza vaccination and the risk of COVID-19 infection and severe illness in older adults in the United States. Sci Rep 2021;11:11025. [PMID: 34040014 DOI: 10.1038/s41598-021-90068-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
11 Wang R, Liu M, Liu J. The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies. Vaccines (Basel) 2021;9:529. [PMID: 34065294 DOI: 10.3390/vaccines9050529] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 27.0] [Reference Citation Analysis]
12 Masse S, Bonnet C, Vilcu AM, Benamar H, Swital M, van der Werf S, Carrat F, Hanslik T, Blanchon T, Falchi A. Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings? Viruses 2021;13:761. [PMID: 33926069 DOI: 10.3390/v13050761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]